Accretion Pharmaceuticals Limited (NSE:ACCPL)
India · Delayed Price · Currency is INR 195.00
+4.50 (2.36%)
At close: Aug 17, 2026
Accretion Pharmaceuticals Market Cap
Accretion Pharmaceuticals has a market cap or net worth of 2.17 billion as of August 17, 2026. Its market cap has increased by 219.67% in one year.
Market Cap
2.17B
Enterprise Value
2.25B
Revenue
896.27M
Ranking
n/a
PE Ratio
21.59
Stock Price
195.00
ChartMarket Cap Chart
Since May 21, 2025, Accretion Pharmaceuticals's market cap has increased from 922.07M to 2.17B, an increase of 135.08%. That is a compound annual growth rate of 99.12%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 17, 2026 | 2.17B | 121.97% |
| Dec 31, 2025 | 976.54M | 5.91% |
| May 21, 2025 | 922.07M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Astonea Labs | 2.92B |
| Everest Organics | 2.81B |
| Gennex Laboratories | 2.63B |
| Oxygenta Pharmaceutical | 2.42B |
| Sanjivani Paranteral | 2.40B |
| Coral Laboratories | 2.05B |
| Kerala Ayurveda | 2.04B |
| Sat Kartar Life | 1.91B |